Skip to main content

Table 1 Main clinical features, examination, treatment and prognosis in 6 children with anti-mGluR5 encephalitis

From: Anti-metabolic glutamate receptor 5 encephalitis with gangliocytoma: a case and review of the literature

Patient sex, age (y)

Prodromal features

Main clinical features

Tumor

CSF analysis

MRI

Treatment

Last follow-up, mo; outcome;

Patient1 M,15

Headache, nausea

Confusion, auditory and visual hallucinations, decreased verbal output, attention deficit, status epilepticus

Hodgkin's lymphoma

114 WBC, OCB

Bilateral (left > right) posterior cortical diffusion restriction

Chemotherapy, RT

72; Complete recovery

Patient2 F,16

Headache

Psychosis, hallucinations, poor sleep, dystonia, generalized seizures

Hodgkin's lymphoma

31 WBC, OCB

Normal

Steroids, chemotherapy, PE

48; Symptoms of Neurological symptom and tumor recurrence

Patient3 F,6

Rash, headache, flulike symptoms

Status epilepticus, dLOC, memory loss, poor sleep with altered sleep–wake cycle, followed by dystonia and oculogyric crisis, psychomotor slowness, ataxia, speech and motor regression, hypoventilation

None

21WBC OCB negative

Bilateral frontal (left > right) and right occipital lobes, cerebellum

Steroids, IVIg, RTX

19; Partial, improved aphasia, cannot walk unassisted

Patient4 M,15

None

Facial paralysis, then developed altered behavior, memory loss, anxiety, irritability, visual hallucinations, insomnia

Hodgkin's lymphoma

45 WBC, OCB

Normal

Steroids, IVIg, chemotherapy

12; Moderate memory problems

Patient5 F,15

loss of appetite

Psychobehavioral abnormalities, seizures, generalized myoclonus

None

Normal

Mild cerebral atrophy

Steroids, IVIg

3; Lethargy

Patient6 M,12 this case

headache, intermittent fever

hallucination and auditory hallucination, mental disorders, sleep disorder

gangliocytoma

90.0 WBC, OCB

encephalitis in limbic

Steroids, IVIg resection of gangliocytoma

3;occasional hallucinations mentioned

  1. Abbreviations: dLOC decreased level of consciousness, IgG immunoglobulin G, IVIg IV immunoglobulin, mGluR5 metabotropic glutamate receptor 5, OCB CSF oligoclonal bands, PE plasma exchange, RT radiotherapy, RTX rituximab, WBC white blood cells per mm